Human hybridoma technology for the production of m
A new method of creating cell lines has been developed for the production of "totally human" monoclonal antibodies.
Professor Hans Coster and Dr David Monaghan, FuCel (June 2000)
Keywords: biopharm, bioreactor, genetic engineering, microbial, cell culture, cell separation, genetics, genomics, biosensors, molecular biology, microbiological testing, microbiology, protein engineering, oligonucleotides, collaboration, biotech research, company news, events, biomedical, industry, government, life sciences, education,
investor, publications, medicine, medical, genes, genetic, engineering, recombinant, cell
therapy, microbiology, pharmacology, sequencing, bioengineering, chromosome, genetics, protein, CAT, galactosidase, NPT, immunofluorescense, antibody, chromatography, filtration, nucleotide, m13, lambda, instaprep, perfectprep, bigprep, PerfectRNA, subventions, FuCell Pty Ltd, human hybridoma technology, monoclonal antibodies